Free shipping on all orders over $ 500

VKGILS-NH2

Cat. No. M10238

All AbMole products are for research use only, cannot be used for human consumption.

VKGILS-NH2 Structure
Size Price Availability Quantity
5mg USD 118 In stock
10mg USD 195 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

VKGILS-NH2 is a reversed amino acid sequence control peptide for SLIGKV-NH2.

Chemical Information
Molecular Weight 614.78
Formula C28H54N8O7
CAS Number 942413-05-0
Solubility (25°C) DMSO 70 mg/mL
Storage -20°C, sealed
References

[1] David A Vesey, et al. Am J Physiol Renal Physiol. Proinflammatory and proliferative responses of human proximal tubule cells to PAR-2 activation

[2] M Tognetto, et al. Br J Pharmacol. Evidence that PAR-1 and PAR-2 mediate prostanoid-dependent contraction in isolated guinea-pig gallbladder

Related PAR Products
ML161

Parmodulin 2 (ML161) is an allosteric inhibitor of PAR1 with IC50 of 0.26 μM.

Vorapaxar

Vorapaxar (SCH 530348) is a potent and orally active thrombin receptor (PAR-1) antagonist with Ki of 8.1 nM.

Vorapaxar Sulfate

Vorapaxar is a first-in-class, potent and orally-active protease-activated receptor 1 (PAR-1) antagonist that blocks thrombin-mediated platelet activation without interfering with thrombin-mediated fibrin deposition.

ML354

ML354 is a potent and selective PAR4 (protease activated receptor-4) antagonist.

PAR-4 (1-6) (human)

PAR-4 (1-6) (human) is an N-terminal fragment of protease-activated receptor 4 (PAR4) that acts as a PAR4 agonist.

  Catalog
Abmole Inhibitor Catalog




Keywords: VKGILS-NH2 supplier, PAR, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.